Stevanato News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stevanato. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stevanato Today - Breaking & Trending Today

Stevanato Group Announces Change in Ex-Dividend Date for its Dividend

Stevanato Group S.p.A. , a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today. | June 7, 2023 ....

New York Stock Exchange , York Stock Exchange , Stevanato Group , Stevanato Groups Pa Stock Exchange , Press Release , Nnounced Stvn It0005452658 ,

Stevanato Group Reports First Quarter 2023 Financial Results

PIOMBINO DESE, Italy (BUSINESS WIRE) Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology ....

United States , United Kingdom , Franco Stevanato , Franco Moro , Stevanato Group , Development Expenses , Solutions Segment , Company Investor Relations , Exchange Commission , Chief Executive Officer , Diagnostic Solutions Segment , Order Intake , Investor Relations , States Toll Free , Constant Currency Revenue , Adjusted Operating Profit , Adjusted Operating Profit Margin , Adjusted Net Profit , Adjusted Diluted , Capital Employed , Net Cash , Free Cash Flow , Marketing Expenses , Administrative Expenses , Constant Currency , Operating Profit ,

Stevanato Group S.p.A.: Stevanato Group Reports First Quarter 2023 Financial Results

- Reiterates Full Year 2023 Guidance - Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology ....

United States , United Kingdom , Franco Stevanato , Franco Moro , Development Expenses , Stevanato Group , Exchange Commission , Company Investor Relations , Solutions Segment , Full Year , Chief Executive Officer , Diagnostic Solutions Segment , Order Intake , Investor Relations , States Toll Free , Constant Currency Revenue , Adjusted Operating Profit , Adjusted Operating Profit Margin , Adjusted Net Profit , Adjusted Diluted , Capital Employed , Net Cash , Free Cash Flow , Marketing Expenses , Administrative Expenses , Constant Currency ,

Stevanato Group S.p.A.: Stevanato Group to Present at BofA Securities Healthcare Conference

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced ....

Las Vegas , Stevanato Group , Bofa Securities Healthcare Conference ,

Stevanato Group to Report First Quarter 2023 Financial Results on May 4, 2023

Stevanato Group S.p.A. , a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today. | April 17, 2023 ....

United Kingdom , United States , Company Investor Relations , Stevanato Group , Investor Relations , States Toll Free , Stevanato Groups Pa Stock Exchange , Press Release , Nnounced Stvn It0005452658 ,